Stay updated on Tirzepatide vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.

Latest updates to the Tirzepatide vs Insulin Glargine in Type 2 Diabetes Clinical Trial page
- ChecktodayChange DetectedA notice about NIH’s transition from “Artificial Intelligence” to “Super Intelligence” appears above the study record history.SummaryDifference0.4%

- Check7 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov revision as v3.7.2 instead of v3.7.1.SummaryDifference0.1%

- Check14 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.1%

- Check35 days agoChange DetectedThe study record history now includes a new revision (v3.7.0) indicating an updated version of the record. The previous revision (v3.6.6) has been removed from the history list.SummaryDifference0.1%

- Check56 days agoChange DetectedThe record history now lists Revision: v3.6.6 as the latest entry and no longer shows Revision: v3.6.5.SummaryDifference0.1%

- Check77 days agoChange DetectedA new revision tag v3.6.5 was added to the history and the previous tag v3.6.4 was removed, signaling a new version in the record’s history without altering substantive study information.SummaryDifference0.1%

Stay in the know with updates to Tirzepatide vs Insulin Glargine in Type 2 Diabetes Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide vs Insulin Glargine in Type 2 Diabetes Clinical Trial page.